Article
Global M&A Trends: 5 Notable Q1 2026 Cases Out Of The US, EU, And UK
Competition authorities in the US, EU, and UK took divergent approaches to merger review in Q1 2026, with American regulators pursuing targeted healthcare remedies and deal abandonments, the European Commission deploying its new Foreign Subsidies Regulation to impose conditions on state-backed acquisitions, and the UK's CMA clearing a concentrated market transaction without intervention. These cases reveal how enforcement priorities and regulatory frameworks are shaping deal execution risk across major juri
McDermott Will & Schulte